172 related articles for article (PubMed ID: 32634278)
1. Liver mitochondrial DNA damage and genetic variability of Cytochrome b - a key component of the respirasome - drive the severity of fatty liver disease.
Pirola CJ; Garaycoechea M; Flichman D; Castaño GO; Sookoian S
J Intern Med; 2021 Jan; 289(1):84-96. PubMed ID: 32634278
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease.
Pirola CJ; Gianotti TF; Burgueño AL; Rey-Funes M; Loidl CF; Mallardi P; Martino JS; Castaño GO; Sookoian S
Gut; 2013 Sep; 62(9):1356-63. PubMed ID: 22879518
[TBL] [Abstract][Full Text] [Related]
3. In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases.
Seki S; Kitada T; Yamada T; Sakaguchi H; Nakatani K; Wakasa K
J Hepatol; 2002 Jul; 37(1):56-62. PubMed ID: 12076862
[TBL] [Abstract][Full Text] [Related]
4. Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis.
Bellanti F; Villani R; Facciorusso A; Vendemiale G; Serviddio G
Free Radic Biol Med; 2017 Oct; 111():173-185. PubMed ID: 28109892
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial genome architecture in non-alcoholic fatty liver disease.
Sookoian S; Flichman D; Scian R; Rohr C; Dopazo H; Gianotti TF; Martino JS; Castaño GO; Pirola CJ
J Pathol; 2016 Dec; 240(4):437-449. PubMed ID: 27577682
[TBL] [Abstract][Full Text] [Related]
6. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
Suppli MP; Rigbolt KTG; Veidal SS; Heebøll S; Eriksen PL; Demant M; Bagger JI; Nielsen JC; Oró D; Thrane SW; Lund A; Strandberg C; Kønig MJ; Vilsbøll T; Vrang N; Thomsen KL; Grønbæk H; Jelsing J; Hansen HH; Knop FK
Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G462-G472. PubMed ID: 30653341
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease.
Paradies G; Paradies V; Ruggiero FM; Petrosillo G
World J Gastroenterol; 2014 Oct; 20(39):14205-18. PubMed ID: 25339807
[TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction.
Boland ML; Oldham S; Boland BB; Will S; Lapointe JM; Guionaud S; Rhodes CJ; Trevaskis JL
World J Gastroenterol; 2018 Apr; 24(16):1748-1765. PubMed ID: 29713129
[TBL] [Abstract][Full Text] [Related]
9. The Non-Invasive Assessment of Circulating D-Loop and mt-ccf Levels Opens an Intriguing Spyhole into Novel Approaches for the Tricky Diagnosis of NASH.
Paolini E; Longo M; Corsini A; Dongiovanni P
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768654
[TBL] [Abstract][Full Text] [Related]
10. Targeted Analysis of Three Hormonal Systems Identifies Molecules Associated with the Presence and Severity of NAFLD.
Polyzos SA; Perakakis N; Boutari C; Kountouras J; Ghaly W; Anastasilakis AD; Karagiannis A; Mantzoros CS
J Clin Endocrinol Metab; 2020 Mar; 105(3):e390-400. PubMed ID: 31690932
[TBL] [Abstract][Full Text] [Related]
11. A Diet Induced Maladaptive Increase in Hepatic Mitochondrial DNA Precedes OXPHOS Defects and May Contribute to Non-Alcoholic Fatty Liver Disease.
Malik AN; Simões ICM; Rosa HS; Khan S; Karkucinska-Wieckowska A; Wieckowski MR
Cells; 2019 Oct; 8(10):. PubMed ID: 31597406
[TBL] [Abstract][Full Text] [Related]
12. Increased hepatic oxidative DNA damage in patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma.
Tanaka S; Miyanishi K; Kobune M; Kawano Y; Hoki T; Kubo T; Hayashi T; Sato T; Sato Y; Takimoto R; Kato J
J Gastroenterol; 2013 Nov; 48(11):1249-58. PubMed ID: 23329365
[TBL] [Abstract][Full Text] [Related]
13. Human Mitochondrial Cytochrome b Variants Studied in Yeast: Not All Are Silent Polymorphisms.
Song Z; Laleve A; Vallières C; McGeehan JE; Lloyd RE; Meunier B
Hum Mutat; 2016 Sep; 37(9):933-41. PubMed ID: 27291790
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of 8-hydroxydeoxyguanosine, L-arginine and Glucose Metabolites by Liver Tumor Cells Are the Important Characteristic Features of Metabolic Syndrome and Non-Alcoholic Steatohepatitis-Associated Hepatocarcinogenesis.
Kakehashi A; Suzuki S; Ishii N; Okuno T; Kuwae Y; Fujioka M; Gi M; Stefanov V; Wanibuchi H
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092030
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial dysfunction-related lipid changes occur in nonalcoholic fatty liver disease progression.
Peng KY; Watt MJ; Rensen S; Greve JW; Huynh K; Jayawardana KS; Meikle PJ; Meex RCR
J Lipid Res; 2018 Oct; 59(10):1977-1986. PubMed ID: 30042157
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial 8-hydroxy-2'-deoxyguanosine and coronary artery disease in patients with type 2 diabetes mellitus.
Wang XB; Cui NH; Liu X; Liu X
Cardiovasc Diabetol; 2020 Feb; 19(1):22. PubMed ID: 32075646
[TBL] [Abstract][Full Text] [Related]
17. Ultra-high-field magnetic resonance spectroscopy in non-alcoholic fatty liver disease: Novel mechanistic and diagnostic insights of energy metabolism in non-alcoholic steatohepatitis and advanced fibrosis.
Traussnigg S; Kienbacher C; Gajdošík M; Valkovič L; Halilbasic E; Stift J; Rechling C; Hofer H; Steindl-Munda P; Ferenci P; Wrba F; Trattnig S; Krššák M; Trauner M
Liver Int; 2017 Oct; 37(10):1544-1553. PubMed ID: 28544208
[TBL] [Abstract][Full Text] [Related]
18. A micro-RNA expression signature for human NAFLD progression.
Guo Y; Xiong Y; Sheng Q; Zhao S; Wattacheril J; Flynn CR
J Gastroenterol; 2016 Oct; 51(10):1022-30. PubMed ID: 26874844
[TBL] [Abstract][Full Text] [Related]
19. miR33a/miR33b* and miR122 as Possible Contributors to Hepatic Lipid Metabolism in Obese Women with Nonalcoholic Fatty Liver Disease.
Auguet T; Aragonès G; Berlanga A; Guiu-Jurado E; Martí A; Martínez S; Sabench F; Hernández M; Aguilar C; Sirvent JJ; Del Castillo D; Richart C
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669236
[TBL] [Abstract][Full Text] [Related]
20. Oxidative Stress and Antioxidant Biomarkers in Clinical and Experimental Models of Non-Alcoholic Fatty Liver Disease.
Ore A; Akinloye OA
Medicina (Kaunas); 2019 Jan; 55(2):. PubMed ID: 30682878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]